19403935

Source:http://linkedlifedata.com/resource/pubmed/id/19403935

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0025266, umls-concept:C0205179, umls-concept:C0282460, umls-concept:C0376358, umls-concept:C1176020
pubmed:issue	5
pubmed:dateCreated	2009-4-30
pubmed:abstractText	This study explored the efficacy and tolerability of sunitinib, an inhibitor of tyrosine kinase receptors, in men with castration-resistant prostate cancer (CRPC).
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/5K24CA121990-02, http://linkedlifedata.com/resource/pubmed/grant/K24 CA121990-03
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-10514409, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-10550143, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-11238530, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-11344271, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-12374693, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-12644539, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-12670562, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-14734476, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-14972483, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-15117988, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-15150085, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-15470213, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-15470214, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-16330672, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-17605814, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-18040273, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-18056648, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-18172272, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-18276061, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-18287387, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-18303479, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-18309951, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-18392823, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-18669461, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-18824699, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-19903718, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-7524068, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-8899000, http://linkedlifedata.com/resource/pubmed/commentcorrection/19403935-9733517
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Angiogenic Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Phytogenic, http://linkedlifedata.com/resource/pubmed/chemical/Indoles, http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen, http://linkedlifedata.com/resource/pubmed/chemical/Protein Kinase Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles, http://linkedlifedata.com/resource/pubmed/chemical/Taxoids, http://linkedlifedata.com/resource/pubmed/chemical/docetaxel, http://linkedlifedata.com/resource/pubmed/chemical/sunitinib
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1569-8041
pubmed:author	pubmed-author:Dror MichaelsonMM, pubmed-author:GurskySS, pubmed-author:KantoffP WPW, pubmed-author:KaufmanD SDS, pubmed-author:KoW HWH, pubmed-author:MichaelsonS ZSZ, pubmed-author:OlivierKK, pubmed-author:ReganM MMM, pubmed-author:SmithM RMR, pubmed-author:SpicerBB
pubmed:issnType	Electronic
pubmed:volume	20
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	913-20
pubmed:dateRevised	2011-9-26
pubmed:meshHeading	pubmed-meshheading:19403935-Adenocarcinoma, pubmed-meshheading:19403935-Aged, pubmed-meshheading:19403935-Aged, 80 and over, pubmed-meshheading:19403935-Angiogenesis Inhibitors, pubmed-meshheading:19403935-Angiogenic Proteins, pubmed-meshheading:19403935-Antineoplastic Agents, Phytogenic, pubmed-meshheading:19403935-Drug Resistance, Neoplasm, pubmed-meshheading:19403935-Humans, pubmed-meshheading:19403935-Indoles, pubmed-meshheading:19403935-Male, pubmed-meshheading:19403935-Middle Aged, pubmed-meshheading:19403935-Prostate-Specific Antigen, pubmed-meshheading:19403935-Prostatic Neoplasms, pubmed-meshheading:19403935-Protein Kinase Inhibitors, pubmed-meshheading:19403935-Pyrroles, pubmed-meshheading:19403935-Taxoids, pubmed-meshheading:19403935-Time Factors, pubmed-meshheading:19403935-Treatment Outcome
pubmed:year	2009
pubmed:articleTitle	Phase II study of sunitinib in men with advanced prostate cancer.
pubmed:affiliation	Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA 02114, USA. dmichaelson1@partners.org
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Clinical Trial, Phase II, Research Support, N.I.H., Extramural